
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced (AE, adverse events; HF, heart failure; LVEF, left ventricular ejection fraction).
Like
Save
Share